Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer.
A Spitz, J M Young, L Larsen, C Mattia-Goldberg, J Donnelly, and K Chwalisz, Prostate Cancer and Prostatic Diseases, 1/1/2012The Use of an Injectable Spacer Material in Conjunction with High Dose-Rate Brachytherapy for Prostate Cancer.
Tokita, K.M., Crittenden, L., Mesa, A., Lane, J., Kibuishi, E., Harrison, J., Gilbert, R., Barme, G., Kobashi, L., Spitz, Aaron, Ravera, J., Brachytherapy, 1/1/2011Efficacy and safety of 6-month depot leuprolide acetate for the treatment of prostate cancer: Results of a 48-week study.
J. Young, A. Spitz, L. Larsen, C. Mattia-Goldberg, J. Donnelly and K. Chwalisz, Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings (PostMeeting Edition), 5/20/2010
